. There are no data on the potential carcinogenicity of EBDCs in humans. In the one study on human genotoxicity, 44 workers producing a fungicide containing mancozeb showed significantly increased chromosomal aberrations (CAs; primarily breaks) in exposed nonsmokers compared to controls and nonsignificant elevations among exposed smokers compared to controls (4. CAs are visible at metaphase as chromosomal breaks or rearrangements and are often lethal to the cell. These same data showed nonsignificant elevations of sister chromatid exchanges (SCEs) of exposed versus nonexposed workers after stratification by smoking. ETU has also been shown to cause a significant decrease in thyroxine (T4) in production workers (mixers) who were highly exposed versus controls, although the number of mixers was small and calculated variances of T4 levels do not appear to have taken into account that there were repeated measures on the same person (3) . ETU has been shown to have the same effects in rodents, causing a decrease in T4 and an increase in thyroid-stimulating hormone (TSH). It has been hypothesized that this disruption of thyroid homeostasis, which correlated with morphological changes in the thyroid gland, may be related to the thyroid tumors observed in rodents (4).
We sought to investigate further the possible cytogenetic and thyrotoxic effects of EBDC fungicides. Our study population was composed of Mexican backpack sprayers applying EBDCs to tomatoes, a group of lesser exposed landowners, and a nonexposed comparison population. Urinary ETU was measured to evaluate current exposure. Cytogenetic outcomes included sister chromatid exchange and chromosome aberrations. The latter outcome was measured by chromosome painting, which enables detection of stable aberrations such as translocations, as well as unstable events such as dicentrics and acentric fragments.
Materials and Methods
Selection ofsubjects. Data were collected on a population of 49 backpack applicators, 14 small landowners, and 31 nonexposed controls who were employed by city government in construction jobs. Blood samples for hormone analysis and questionnaires were also collected from an additional group of 14 controls to replace two shipments of blood, which were delayed in shipment and were damaged because they arrived without ice.
All subjects were males and lived near Cuernavaca in central Mexico. Subjects were selected via contact with small landowners who grow tomatoes in the area. All workers employed by a recruited landowner were also recruited, and recruitment continued until the target sample size of 50 exposed subjects was assured.
Demographic data were collected by questionnaire, including data on smoking and alcohol use. All subjects were compensated $10 for their time and inconvenience, and all subjects signed consent forms explaining the study. All blood was drawn in the morning.
The backpack applicators applied pesticides seasonally (une to November), primarily to tomatoes. Many applicators were migrants who returned to their home province for part of the year. Owners were full-time tomato farmers and were generally present during application; owners were likely to have some exposure, although less than the applicators.
Exposure. Collection ofbiological samples. Different numbers of subjects were available for analysis of different endpoints. Blood was drawn in the morning for both exposed and nonexposed subjects. All blood samples were shipped on ice within 24 hr to the laboratory. For the exposed subjects, an attempt was made to collect blood in the morning on a day exposure took place and to collect the first-void urine the morning of the next day from the same worker. The urinary elimination half-life of ETU in humans has been estimated to be approximately 32-100 hr, with highest levels excreted in the urine in the first 24 hr after exposure (4, 5) .
Most subjects contributed both urine and blood; however, some subjects contributed only one or the other (no subject contributed more than one sample for either blood or urine). The urine was used to confirm exposure and to serve as a basis of comparison with other studies (ETU is generally not present in the urine of individuals without EBDC exposure). Urinary ETS was not used for exposure-response analyses, so having blood and urine samples on the same people was not essential.
Serum thyroid hormone data were originally available on all 31 nonexposed subjects and 51 of 63 exposed subjects. Because two shipments of blood (21 nonexposed, 8 exposed subjects) were delayed and arrived after ice melted in hot summer temperatures (altering hormone levels), these samples could not be used for the hormone analysis, although most were able to be used for cytogenetic analysis. Fourteen additional controls were then recruited, and blood samples were obtained from them for hormone analysis only. Cytogenetic data were available for 30 of 31 nonexposed subjects and 44 of 63 exposed subjects. Urine data were available for all 31 nonexposed subjects and for 50 of 63 exposed subjects. Data were missing for a variety of reasons. Some subjects refused to supply the sample (typically the blood), others failed to collect and/or deliver the sample (typically the urine), and some samples were inadvertently lost in transport (blood).
Urine samples were stored on dry ice and shipped to the lab. Double blind samples spiked with known amounts of ETU were also sent to the lab for quality control and confirmation of the limit of detection. Analysis of urine for ETU was done via high performance liquid chromatography using an electrochemical detector (6), with a limit of detection of 10 ppb.
Blood samples for thyroid hormone analysis were collected in 5-ml serum separation tubes and spun down to separate the erythrocytes prior to shipping. Both T4 and TSH were analyzed via enzyme immunoassays (MEI or microparticle enzyme assay for TSH via IMX, CEDIA enzyme immunoassay for T4). Blood samples for cytogenetic analysis were collected in 7-ml heparinized tubes.
Cytogenetic procedures. Cell culture and cytogenetic analyses were conducted in Livermore, California, without knowledge of the exposure category of samples. Whole blood (0.8 ml) was added to 10 ml of RPMI 1640 medium (Gibco/BRL, Gaithersburg, MD) supplemented with 15% fetal bovine serum, 100 IU/ml penicillin, 100 pg/ml streptomycin, 1% sodium heparin, 2% phytohemagglutinin, and 2 mM L-glutamine. Four cultures were prepared for each subject, two of which were supplemented with 100 mM bromodeoxyuridine (BrdU) to obtain SCEs. Cultures were incubated at 37°C in a 5% CO2 environment. The culture duration was 52 and 72 hr for aberrations and SCEs, respectively; in each case, 0.1 pg/ml Colcemid was added for the last 4 hr of culture. Cells were harvested by swelling in 0.075 M KCl and then fixed a minimum of three times in 3:1 (v/v) methanol:glacial acetic acid. Well-spread metaphase cells, low in cytoplasm, were prepared as described elsewhere (7) . All slides were stored at -20°C in sealed plastic bags in the presence of a desiccant and N2 until needed for hybridization.
For SCEs, slides were stained with the fluorescence-plus-Giemsa method (8, 9 For chromosome painting, slides were hybridized with SpectrumOrange chromosome-specific DNA probe (Vysis, Downers Grove, IL) for chromosomes 1, 2, and 4 simultaneously according to the manufacturer's instructions, with minor modifications as described elsewhere (7, 10) . The There were only seven subjects over 40 years of age in the study, and six ofthese were exposed. Given this imbalance in the highest age category and because of the known importance of age for several outcomes, particularly chromosome translocations (16), we also conducted additional analyses for all outcomes after restricting the subjects to those aged 40 or less.
Smoking was thought a priori to be a potential confounder for sister chromatid exchange and, to a lesser extent, for chromosomal translocations. A dichotomous variable for current smoking was added to models for all outcomes and tested. It was not a significant predictor in any model, possibly because smokers in this population were very light smokers (4-5 cigarettes/day); therefore, the smoking variable was dropped for all models but the SCE analysis. It was retained in the final model for SCEs because it had some predictive value (p = 0.16) and some slight confounding effect on the exposure effect. Alcohol consumption was also tested for both SCEs and CAs, but was not an important predictor for either outcome; it was not included in final models.
Analyses were conducted using SAS (PROC GLM or PROC REG for linear regression, PROC GENMOD for Poisson regression; SAS Institute, Cary, NC) (17) . Table 1 gives the results for age, smoking, and urinary ETU by three exposure categories (nonexposed, owners, applicators). The exposed applicators and owners were somewhat older, on the average, than the nonexposed. The majority of all groups smoked, but smokers smoked few cigarettes (subjects who smoked one cigarette or less per week were considered nonsmokers). All of the nonexposed subjects had urinary ETU below the limit of detection (10 ppb). The same was true for 13 of 38 applicators (34%) and 6 of 12 owners (50%). After assigning half the limit of detection (i.e., 5 ppb) to exposed subjects with an ETU level below the limit of detection, the mean was 58 ppb (geometric mean 19) for applicators and 12 ppb (geometric mean 9) for owners. The ETU exposure of the applicators was somewhat higher than prior urinary data for applicators in Europe (18) (maximum 13 ppb) or for grape thinners exposed to residues in the United States (19) (maximum 25 ppb). Table 2 presents the unadjusted and ageadjusted results of the thyroid hormone analysis. All subjects were within normal limits for all hormone tests. There were no significant differences between groups for T4: the controls and the heavily exposed applicators had virtually identical results. The unadjusted data also showed no significant differences for TSH 12 owners, and 31 nonexposed subjects. All nonexposed subjects had levels below limit of detection (10 ppb) as did 34% of applicators and 50% of landowners. Samples for exposed subjects below the limit of detection were assigned half the limit of detection. Table 3 presents the cytogenetic outcomes by exposure group. Both unadjusted and adjusted (for age, smoking, via linear regression) data indicated that the applicators had significantly higher SCEs than nonexposed controls (0.62 increase in SCE per cell, p = 0.02, adjusted data). Owners were not significantly different from controls. The proportion of variance explained by the regression model was 22%. Table 3 also presents the unadjusted and age-adjusted results for chromosomal aberrations. The unadjusted data show significant differences between applicators and owners compared to nonexposed controls for translocations and for the subset of reciprocal translocations. However, translocations increase markedly with age, and age acts as a confounder in these data. The Poisson regression analyses controlling for age indicated that applicators had significantly more total translocations than did the nonexposed subjects (1.50 increase, p = 0.05), while owners had a nonsignificant increase (0.85 increase, p = 0.31). Additional analyses using terms for age and age squared to control for age, rather than age categories, yielded essentially the same results. Analyses restricted to those age 40 and below resulted in a slightly lower predicted increase for applicators (1.25 translocations) compared to the nonexposed (p = 0.14). Analyses restricted to reciprocal translocations also yielded a lower and nonsignificant exposure effect for applicators versus the nonexposed (p = 0.24).
Results
Poisson regression analyses of other chromosome outcomes (dicentrics, insertions, fragments, and rings) did not show any significant differences between the exposed group and the nonexposed referents.
Total translocations and reciprocal translocations were both significantly correlated with SCEs, with Spearman correlations of 0.28 (p = 0.02) and 0.27 (p = 0.02), respectively.
Discussion
We have studied two groups of subjects exposed to EBDCs during application to tomatoes in Mexico. Urinary ETU data confirmed that the applicators were more highly exposed than the landowners, while Although all the thyroid hormone data were within normal range, after age-adjustment the TSH level was significantly increased in the applicators compared to the nonexposed subjects (and nonsignificantly increased among the landowners, suggesting a dose response). In our data, age was negatively correlated with TSH and acted as a negative confounder. Several reports in the literature indicate that TSH levels decrease with age in healthy populations (21, 22) , but other studies have not shown such an effect (23) . The exposure effect for applicators versus nonexposed controls for TSH was also apparent without age adjustment (p = 0.07) when the data were restricted to younger subjects (<30 years of age, 87% of applicators and controls).
Because T4 levels were not decreased among the exposed compared to the nonexposed, TSH may be a more sensitive indicator of an effect on the thyroid than T4 levels (20) . Most of these workers had been exposed to EBDCs and ETU for several weeks or months at the time of testing; homeostasis with normal T4 but elevated TSH might be expected after several weeks of exposure (24) . The effect on TSH is consistent with animal data (1) . In the one study of ETU-production workers with presumed high exposure, the five most highly exposed mixers had significantly decreased T4 and one had abnormally high TSH with dinical signs of premyxedema (3 affected subjects could not continue in this type of relatively strenuous work. Our data on genotoxic outcomes indicate that the applicators had significantly increased SCEs, with or without adjustment for age and smoking. Chromosome translocations were significantly elevated for both applicators and owners (p<0.001) before age adjustment, compared to nonexposed subjects. However, age acted as a positive confounder in these data; after age adjustment, the exposure effect was diminished, although it was still present for applicators versus nonexposed controls (p = 0.05). When analyses were restricted to the subset of reciprocal translocations, the increase for applicators failed to reach conventional statistical significance after age adjustment (p = 0.24). In the age-adjusted data, again the landowners showed less pronounced elevations than applicators, suggesting a possible dose response. Reciprocal translocations are thought to be more stable than nonreciprocal translocations (13) , and the somewhat more pronounced effect seen for all translocations (including nonreciprocals) may reflect the effects of more recent exposure. Chromosome outcomes other than translocations did not significantly differ between the exposed subjects and controls, but most of these outcomes were quite rare and results lack statistical precision.
The increased SCEs indicate that exposure is affecting the genome, but it is not established that increased levels of SCEs are predictive of cancer or any other health outcome. The one epidemiologic study on the question has not, to date, observed any effect of elevated SCEs on cancer, based on 6 years of follow-up and 49 observed cancers in a Nordic 6-year prospective study of 3,182 people (25) . The increased levels of all translocations are somewhat more worrisome, as translocations are common in tumors and often occur at sites of genes affecting cell cycle and tumor suppression (26) . Increased levels of chromosome breaks have been shown to be predictive of cancer in humans in the same Nordic study cited above (66 cancers observed) (25) . Those (27) after control for smoking and occupational exposures.
There is some potential for confounding of the genotoxic results by other genotoxic pesticides, specifically by another fungicide, captan. Captan has been found to be mutagenic in some animal and bacterial systems and has been found to cause cancer in some rodent studies (28) . However, captan use has been uncommon in tomato application; owners relied primarily on EBDCs. The organophosphate pesticides commonly used with the EBDCs are not generally genotoxic.
In conclusion, our data are consistent with animal and some human data in suggesting a toxic effect of EBDCs on the thyroid and on the genome (SCEs, chromosomal translocations). However, the exposure effects observed in our study were subclinical and of uncertain future clinical significance. Furthermore, exposure effects were modest, generally on the borderline of conventional statistical significance, and were based on a single field study with limited sample size. The observed effects should therefore be interpreted with caution.
